SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-300949
Filing Date
2014-08-07
Accepted
2014-08-07 17:12:55
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d760215d10q.htm 10-Q 565682
2 EX-31.1 d760215dex311.htm EX-31.1 7642
3 EX-31.2 d760215dex312.htm EX-31.2 7649
4 EX-32.1 d760215dex321.htm EX-32.1 2793
5 EX-32.2 d760215dex322.htm EX-32.2 2807
  Complete submission text file 0001193125-14-300949.txt   3772305

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT agio-20140630.xml EX-101.INS 461325
7 XBRL TAXONOMY EXTENSION SCHEMA agio-20140630.xsd EX-101.SCH 36135
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agio-20140630_cal.xml EX-101.CAL 51990
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agio-20140630_def.xml EX-101.DEF 108267
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20140630_lab.xml EX-101.LAB 320023
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20140630_pre.xml EX-101.PRE 221060
Mailing Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-272-5275
AGIOS PHARMACEUTICALS INC (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 141024794
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences